Thymic tumor with adenoid cystic carcinomalike features: A clinicopathologic study of 4 cases

American Journal of Surgical Pathology

Volumn 31, Issue 8, 2007, Pages 1161-1167

  Di Tommaso, Luca ^a,e   Kuhn, Elisabetta ^b   Kurrer, Michael ^c   Zettl, Andreas ^d   Marx, Alex ^d   Müller Hermelink, Hans Konrad ^d   Roncalli, Massimo ^a   Rosai, Juan ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Centro Diagnostico Italiano   (Italy)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Adenoid cystic carcinoma; CGH; Immunohistochemistry; Thymic carcinoma; Thymus

Indexed keywords

CHROMOGRANIN; COLLAGEN TYPE 4; LAMININ; MUCIN; SYNAPTOPHYSIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CHROMOSOME 8; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROSCOPY; MITOSIS; MORPHOLOGY; PSEUDOCYST; RADIODIAGNOSIS; SALIVARY GLAND; T LYMPHOCYTE; THYMOMA; TUMOR CELL;

AGED; ANEUPLOIDY; CARCINOMA, ADENOID CYSTIC; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIOGRAPHY, THORACIC; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547641362     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3180555ba8     Document Type: Article

References (28)

1. Albers E, Lawrie T, Harrell JH, et al. Tracheobronchial adenoid cystic carcinoma: a clinicopathologic study of 14 cases. Chest. 2004;125:1160-1165.
2. Azoulay S, Lae M, Freneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18:1623-1631.
3. Babu MK, Nirmala V. Thymic carcinoma with glandular differentiation arising in a congenital thymic cyst. J Surg Oncol. 1994;57:277-279.
4. Chetty R, Serra S, Hsieh E. Basaloid squamous carcinoma of the anal canal with an adenoid cystic pattern: histologic and immunohistochemical reappraisal of an unusual variant. Am J Surg Pathol. 2005;29:1668-1672.
5. Choi WW, Lui YH, Lau WH, et al. Adenocarcinoma of the thymus: report of two cases, including a previously undescribed mucinous subtype. Am J Surg Pathol. 2003;27:124-130.
6. Dorfman DM, Shahsafaei A, Chan JK. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol. 1997;21:936-940.
7. Franke A, Strobel P, Fackeldey V, et al. Hepatoid thymic carcinoma: report of a case. Am J Surg Pathol. 2004;28:250-256.
8. Hishima T, Fukayama M, Hayashi Y, et al. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hum Pathol. 1998;29:330-338.
9. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003;63:3708-3715.
10. Kornstein MJ, Rosai J. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol. 1998;109:722-726.
11. Lauriola L, Erlandson RA, Rosai J. Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol. 1998;22:1059-1066.
12. Li TJ, Zhang YX, Wen J, et al. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004;128:1124-1130.
13. Lichter P, Bentz M, Du Manoir S, et al. Comparative genomic hybridization. In: Verma RS, Babu A, eds. Human Chromosomes: Principles and Techniques. 2nd ed. New York: McGraw-Hill; 1995: 191-210.
14. Marx A, Muller-Hermelink HK. Thymoma and thymic carcinoma. Am J Surg Pathol. 1999;23:739-742.
15. McKenney JK, Amin MB, Srigley JR, et al. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol. 2004;28:1289-1298.
16. Moran CA, Suster S, Koss MN. Primary adenoid cystic carcinoma of the lung. A clinicopathologic and immunohistochemical study of 16 cases. Cancer. 1994;73:1390-1397.
17. Nakagawa K, Matsuno Y, Kunitoh H, et al. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest. 2005;128:140-144.
18. Pan CC, Chen PC, Chou TY, et al. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol. 2003;34:1155-1162.
19. Pan CC, Chen PC, Chiang H. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol. 2004;202:375-381.
20. Penzel R, Hoegel J, Schmitz W, et al. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer. 2003;105:494-498.
21. Pomplun S, Wotherspoon AC, Shah G, et al. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology. 2002;40:152-158.
22. Rosen PP. Adenoid cystic carcinoma. In: Rosen's Breast Pathology. Philadelphia: Lippincott Willilams & Wilkins; 1997:465.
23. Snover DC, Levine GD, Rosai J. Thymic carcinoma. Five distinct histological variants. Am J Surg Pathol. 1982;6:451-470.
24. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinico-pathologic study of 22 cases. Am J Surg Pathol. 1996;20:1469-1480.
25. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67:1025-1032.
26. Tateyama H, Eimoto T, Tada T, et al. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol. 1999;111:235-240.
27. Travis WD, Brambilla E, Müller-Hermelink HK, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.
28. Zettl A, Strobel P, Wagner K, et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol. 2000;157:257-266.